QCM
FLGT icon

Quantinno Capital Management’s Fulgent Genetics FLGT Stock Holding History

Quantinno Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
115,406
-22,073
-16% -$374K ﹤0.01% 1830
2026
Q1 		$2.19M Buy
137,479
+108,519
+375% +$2.36M ﹤0.01% 1565
2025
Q4 		$761K Buy
28,960
+3,147
+12% +$81.6K ﹤0.01% 2008
2025
Q3 		$583K Sell
25,813
-3,604
-12% -$74.2K ﹤0.01% 1877
2025
Q2 		$585K Buy
29,417
+14,480
+97% +$282K ﹤0.01% 1562
2025
Q1 		$252K Buy
14,937
+1,858
+14% +$31.6K ﹤0.01% 1720
2024
Q4 		$242K Buy
+13,079
New +$255K ﹤0.01% 1471

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantinno Capital Management's FLGT Position: Q2 2026 in Review

Quantinno Capital Management reduced its Fulgent Genetics (FLGT) stake by 16% in Q2 2026, selling an estimated $374K and leaving 115,406 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

Quantinno Capital Management first reported a position in FLGT in Q4 2024 and has held it in 7 quarters since. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Quantinno Capital Management held 115,406 shares of Fulgent Genetics worth $2.37M as of Q2 2026.
  • Quantinno Capital Management sold 22,073 Fulgent Genetics shares in Q2 2026, an estimated $374K.
  • Fulgent Genetics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1830 holding.
  • Quantinno Capital Management first reported a position in Fulgent Genetics in Q4 2024 and has held it in 7 quarters since.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.